AFANIX 40 MG
Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
AXINIX 1 MG
Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior
AXINIX 5 MG
DESCRIPTION Axinix (Axitinib) is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one
BARICINIX 2 MG
Product Description: Baricitinib is indicated for the treatment of moderate to severely active rheumatoid arthritis in adult patients who have
BARICINIX 4 MG
Product Description: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded
CABOZANIB 80 MG
CABOZANIB 80 MG/*54745756836*/
CABOZANIX 20 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
CABOZANIX 60 MG
CABOZANIX 60 MG/*54745756836*/
CABOZANIX 80 MG
Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
CAZER 80 _ 20 MG
CAZER 80 _ 20 MG/*54745756836*/
COVIRIN 200MG
Covirin Capsule 200 mg Indications Ribavirin is indicated for the treatment of chronic hepatitis C (CHC) virus infection in combination with
CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including